russjcardiolРоссийский кардиологический журналRussian Journal of Cardiology1560-40712618-7620«SILICEA-POLIGRAF» LLC10.15829/1560-4071-2023-5714IFRIZKrussjcardiol-5714Research ArticleОБЗОРЫ ЛИТЕРАТУРЫREVIEWРоль бесшовных технологий для хирургии аортального клапана в эру транскатетерных клапановRole of sutureless aortic valve replacement in the era of transcatheter valveshttps://orcid.org/0000-0001-9988-2653ЦароевБ. С.TsaroevB. S.

Цароев Башир Салманович — м.н.с. научно-исследовательского отдела новых хирургических технологий института патологии кровообращения, сердечно-сосудистый хирург

Новосибирск

Novosibirsk

bashir.tsaroev@yahoo.comhttps://orcid.org/0000-0003-4625-4631Богачев-ПрокофьевА. В.Bogachev-ProkofievA. V.

Богачев-Прокофьев Александр Владимирович — директор института патологии кровообращения, сердечно-сосудистый хирург

Новосибирск

Novosibirsk

bogachev.prokophiev@gmail.comhttps://orcid.org/0000-0002-8832-2447ШарифулинР. М.SharifulinR. M.

Шарифулин Равиль Махарамович — с.н.с. института патологии кровообращения, сердечно-сосудистый хирург

Новосибирск

Novosibirsk

ravil-sharifulin@rambler.ruhttps://orcid.org/0000-0001-7373-6308АфанасьевА. В.AfanasyevA. V.

Афанасьев Александр Владимирович — в.н.с. института патологии кровообращения, сердечно-сосудистый хирург

Новосибирск

Novosibirsk

av.afanasyev@icloud.comhttps://orcid.org/0000-0001-9818-8678ЧернявскийА. М.ChernyavskyA. M.

Чернявский Александр Михайлович — генеральный директор, сердечно-сосудистый хирург.

Новосибирск

Novosibirsk

a_cherniavsky@meshalkin.ruФГБУ Национальный исследовательский медицинский центр им. акад. Е.Н. Мешалкина Минздрава РоссииРоссияMeshalkin National Research Medical CenterRussian Federation202320122023281257145714Copyright © Цароев Б.С., Богачев-Прокофьев А.В., Шарифулин Р.М., Афанасьев А.В., Чернявский А.М., 20232023Цароев Б.С., Богачев-Прокофьев А.В., Шарифулин Р.М., Афанасьев А.В., Чернявский А.М.Tsaroev B.S., Bogachev-Prokofiev A.V., Sharifulin R.M., Afanasyev A.V., Chernyavsky A.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://russjcardiol.elpub.ru/jour/article/view/5714

В обзорной статье рассматривается роль технологий бесшовного протезирования аортального клапана в эру транскатетерного протезирования. Освещены современные данные относительно результатов лечения этими двумя методиками, проведено сравнение двух методик, подробно описаны их основные недостатки, определены когорты пациентов оптимальные для той или иной методики протезирования.

This review article considers the role of sutureless aortic valve replacement in the era of transcatheter replacement. Modern data regarding the outcomes of treatment with these two methods and its comparison are considered. Their main disadvantages and the cohorts of patients suitable for each technique are determined.

протезирование аортального клапанааортальный стенозтранскатетерные клапаныклапаны для бесшовной имплантацииaortic valve replacementaortic stenosistranscatheter valvesvalves for sutureless implantationИсследование выполнено в рамках гранта Российского научного фонда № 23-15-00434The study was carried out within the Russian Science Foundation grant № 23-15-00434ReferencesBonow RO, Otto CM. Valvular Heart Disease: A Companion to Braunwald's Heart Disease. 4th Editio. Elsevier Saunders. 2014. ISBN 9781455758401.Bonow RO, Otto CM. Valvular Heart Disease: A Companion to Braunwald's Heart Disease. 4th Editio. Elsevier Saunders. 2014. ISBN 9781455758401.Argulian E, Windecker S, Messerli FH. Misconceptions and Facts About Aortic Stenosis. Am J Med. 2017;130:398-402. doi:10.1016/j.amjmed.2016.12.025.Argulian E, Windecker S, Messerli FH. Misconceptions and Facts About Aortic Stenosis. Am J Med. 2017;130:398-402. doi:10.1016/j.amjmed.2016.12.025.Osnabrugge RLJ, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62:1002-12. doi:10.1016/j.jacc.2013.05.015.Osnabrugge RLJ, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62:1002-12. doi:10.1016/j.jacc.2013.05.015.Costa G, Criscione E, Reddavid C, Barbanti M.Balloon-expandable versus self-expanding transcatheter aortic valve replacement: a comparison and evaluation of current findings. Expert Rev Cardiovasc Ther. 2020;18:697-708. doi:10.1080/14779072.2020.1807326.Costa G, Criscione E, Reddavid C, Barbanti M.Balloon-expandable versus self-expanding transcatheter aortic valve replacement: a comparison and evaluation of current findings. Expert Rev Cardiovasc Ther. 2020;18:697-708. doi:10.1080/14779072.2020.1807326.Leon MB, Smith CR, Mack M, et al. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. N Engl J Med. 2010;363:1597-607. doi:10.1056/NEJMoa1008232.Leon MB, Smith CR, Mack M, et al. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. N Engl J Med. 2010;363:1597-607. doi:10.1056/NEJMoa1008232.Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016;374:1609-20. doi:10.1056/NEJMoa1514616.Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016;374:1609-20. doi:10.1056/NEJMoa1514616.Mack MJ, Leon MB, Thourani VH, et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019;380:1695-705. doi:10.1056/NEJMoa1814052.Mack MJ, Leon MB, Thourani VH, et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019;380:1695-705. doi:10.1056/NEJMoa1814052.Hansson NC, Grove EL, Andersen HR, et al. Transcatheter Aortic Valve Thrombosis: Incidence, Predisposing Factors, and Clinical Implications. J Am Coll Cardiol. 2016;68:2059-69. doi:10.1016/j.jacc.2016.08.010.Hansson NC, Grove EL, Andersen HR, et al. Transcatheter Aortic Valve Thrombosis: Incidence, Predisposing Factors, and Clinical Implications. J Am Coll Cardiol. 2016;68:2059-69. doi:10.1016/j.jacc.2016.08.010.Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-98. doi:10.1056/NEJMoa1103510.Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-98. doi:10.1056/NEJMoa1103510.Astarci P, Glineur D, Kefer J, et al. Magnetic resonance imaging evaluation of cerebral embolization during percutaneous aortic valve implantation: comparison of transfemoral and trans-apical approaches using Edwards Sapiens valve. Eur J Cardio-Thoracic Surg Off J Eur Assoc Cardio-Thoracic Surg. 2011;40:475-9. doi:10.1016/j.ejcts.2010.11.070.Astarci P, Glineur D, Kefer J, et al. Magnetic resonance imaging evaluation of cerebral embolization during percutaneous aortic valve implantation: comparison of transfemoral and trans-apical approaches using Edwards Sapiens valve. Eur J Cardio-Thoracic Surg Off J Eur Assoc Cardio-Thoracic Surg. 2011;40:475-9. doi:10.1016/j.ejcts.2010.11.070.Chakravarty T, Patel A, Kapadia S, et al. Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement. J Am Coll Cardiol. 2019;74:1190-200. doi:10.1016/j.jacc.2019.06.058.Chakravarty T, Patel A, Kapadia S, et al. Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement. J Am Coll Cardiol. 2019;74:1190-200. doi:10.1016/j.jacc.2019.06.058.Myerson SG. Heart valve disease: investigation by cardiovascular magnetic resonance. J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson. 2012;14:7. doi:10.1186/1532-429X-14-7.Myerson SG. Heart valve disease: investigation by cardiovascular magnetic resonance. J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson. 2012;14:7. doi:10.1186/1532-429X-14-7.Woldendorp K, Doyle MP, Black D, et al. Subclinical valve thrombosis in transcatheter aortic valve implantation: A systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2021;162:1491-9.e2. doi:10.1016/j.jtcvs.2020.01.084.Woldendorp K, Doyle MP, Black D, et al. Subclinical valve thrombosis in transcatheter aortic valve implantation: A systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2021;162:1491-9.e2. doi:10.1016/j.jtcvs.2020.01.084.Bogyi M, Schernthaner RE, Loewe C, et al. Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement: A Meta-Analysis. JACC Cardiovasc Interv. 2021;14:2643-56. doi:10.1016/j.jcin.2021.09.019.Bogyi M, Schernthaner RE, Loewe C, et al. Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement: A Meta-Analysis. JACC Cardiovasc Interv. 2021;14:2643-56. doi:10.1016/j.jcin.2021.09.019.Mack MJ, Leon MB, Thourani VH, et al. Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years. N Engl J Med. 2023;389(21):1949-60. doi:10.1056/NEJMoa2307447.Mack MJ, Leon MB, Thourani VH, et al. Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years. N Engl J Med. 2023;389(21):1949-60. doi:10.1056/NEJMoa2307447.Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardio-Thoracic Surg Off J Eur Assoc Cardio-Thoracic Surg. 2021;60:727-800. doi:10.1093/ejcts/ezab389.Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardio-Thoracic Surg Off J Eur Assoc Cardio-Thoracic Surg. 2021;60:727-800. doi:10.1093/ejcts/ezab389.Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/ American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e72-227. doi:10.1161/CIR.0000000000000923.Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/ American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e72-227. doi:10.1161/CIR.0000000000000923.Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement. Ann Thorac Surg. 2021;111:701-22. doi:10.1016/j.athoracsur.2020.09.002.Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement. Ann Thorac Surg. 2021;111:701-22. doi:10.1016/j.athoracsur.2020.09.002.Eggebrecht H, Mehta RH. Transcatheter aortic valve implantation (TAVI) in Germany: more than 100,000 procedures and now the standard of care for the elderly. EuroIntervention J Eur Collab with Work Gr Interv Cardiol Eur Soc Cardiol. 2019;14:e1549-52. doi:10.4244/EIJ-D-18-01010.Eggebrecht H, Mehta RH. Transcatheter aortic valve implantation (TAVI) in Germany: more than 100,000 procedures and now the standard of care for the elderly. EuroIntervention J Eur Collab with Work Gr Interv Cardiol Eur Soc Cardiol. 2019;14:e1549-52. doi:10.4244/EIJ-D-18-01010.Carrel T, Heinisch PP. History, development and clinical perspectives of sutureless and rapid deployment surgical aortic valve replacement. Ann Cardiothorac Surg. 2020;9:375-85. doi:10.21037/acs-2020-surd-18.Carrel T, Heinisch PP. History, development and clinical perspectives of sutureless and rapid deployment surgical aortic valve replacement. Ann Cardiothorac Surg. 2020;9:375-85. doi:10.21037/acs-2020-surd-18.Salis S, Mazzanti V V, Merli G, et al. Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery. J Cardiothorac Vasc Anesth. 2008;22:814-22. doi:10.1053/j.jvca.2008.08.004.Salis S, Mazzanti V V, Merli G, et al. Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery. J Cardiothorac Vasc Anesth. 2008;22:814-22. doi:10.1053/j.jvca.2008.08.004.Chalmers J, Pullan M, Mediratta N, Poullis M. A need for speed? Bypass time and outcomes after isolated aortic valve replacement surgery. Interact Cardiovasc Thorac Surg. 2014;19:21-6. doi:10.1093/icvts/ivu102.Chalmers J, Pullan M, Mediratta N, Poullis M. A need for speed? Bypass time and outcomes after isolated aortic valve replacement surgery. Interact Cardiovasc Thorac Surg. 2014;19:21-6. doi:10.1093/icvts/ivu102.Wesselink RM, de Boer A, Morshuis WJ, Leusink JA. Cardio-pulmonary-bypass time has important independent influence on mortality and morbidity. Eur J Cardio-Thoracic Surg Off J Eur Assoc Cardio-Thoracic Surg. 1997;11:1141-5. doi:10.1016/s1010-7940(97)01217-7.Wesselink RM, de Boer A, Morshuis WJ, Leusink JA. Cardio-pulmonary-bypass time has important independent influence on mortality and morbidity. Eur J Cardio-Thoracic Surg Off J Eur Assoc Cardio-Thoracic Surg. 1997;11:1141-5. doi:10.1016/s1010-7940(97)01217-7.Fischlein T, Folliguet T, Meuris B, et al. Sutureless versus conventional bioprostheses for aortic valve replacement in severe symptomatic aortic valve stenosis. J Thorac Cardiovasc Surg. 2021;161:920-32. doi:10.1016/j.jtcvs.2020.11.162.Fischlein T, Folliguet T, Meuris B, et al. Sutureless versus conventional bioprostheses for aortic valve replacement in severe symptomatic aortic valve stenosis. J Thorac Cardiovasc Surg. 2021;161:920-32. doi:10.1016/j.jtcvs.2020.11.162.D'Onofrio A, Salizzoni S, Filippini C, et al. Surgical aortic valve replacement with new-generation bioprostheses: Sutureless versus rapid-deployment. J Thorac Cardiovasc Surg. 2020;159:432-42.e1. doi:10.1016/j.jtcvs.2019.02.135.D'Onofrio A, Salizzoni S, Filippini C, et al. Surgical aortic valve replacement with new-generation bioprostheses: Sutureless versus rapid-deployment. J Thorac Cardiovasc Surg. 2020;159:432-42.e1. doi:10.1016/j.jtcvs.2019.02.135.Santarpino G, Berretta P, Fischlein T, et al. Operative outcome of patients at low, intermediate, high and 'very high' surgical risk undergoing isolated aortic valve replacement with sutureless and rapid deployment prostheses: results of the SURD-IR registry. Eur J Cardio-Thoracic Surg Off J Eur Assoc Cardio-Thoracic Surg. 2019;56:38-43. doi:10.1093/ejcts/ezy477.Santarpino G, Berretta P, Fischlein T, et al. Operative outcome of patients at low, intermediate, high and 'very high' surgical risk undergoing isolated aortic valve replacement with sutureless and rapid deployment prostheses: results of the SURD-IR registry. Eur J Cardio-Thoracic Surg Off J Eur Assoc Cardio-Thoracic Surg. 2019;56:38-43. doi:10.1093/ejcts/ezy477.Ranucci M, Frigiola A, Menicanti L, et al. Aortic cross-clamp time, new prostheses, and outcome in aortic valve replacement. J Heart Valve Dis. 2012;21:732-9.Ranucci M, Frigiola A, Menicanti L, et al. Aortic cross-clamp time, new prostheses, and outcome in aortic valve replacement. J Heart Valve Dis. 2012;21:732-9.Forcillo J, Bouchard D, Nguyen A, et al. Perioperative outcomes with sutureless versus stented biological aortic valves in elderly persons. J Thorac Cardiovasc Surg. 2016;151:1629-36. doi:10.1016/j.jtcvs.2015.12.056.Forcillo J, Bouchard D, Nguyen A, et al. Perioperative outcomes with sutureless versus stented biological aortic valves in elderly persons. J Thorac Cardiovasc Surg. 2016;151:1629-36. doi:10.1016/j.jtcvs.2015.12.056.Dokollari A, Torregrossa G, Sicouri S, et al. Pearls, pitfalls, and surgical indications of the Intuity TM heart valve: A rapid deployment bioprosthesis. A systematic review of the literature. J Card Surg. 2022;37:5411-7. doi:10.1111/jocs.17231.Dokollari A, Torregrossa G, Sicouri S, et al. Pearls, pitfalls, and surgical indications of the Intuity TM heart valve: A rapid deployment bioprosthesis. A systematic review of the literature. J Card Surg. 2022;37:5411-7. doi:10.1111/jocs.17231.Coti I, Haberl T, Scherzer S, et al. Rapid-Deployment Aortic Valves for Patients With a Small Aortic Root: A Single-Center Experience. Ann Thorac Surg. 2020;110:1549-56. doi:10.1016/j.athoracsur.2020.02.030.Coti I, Haberl T, Scherzer S, et al. Rapid-Deployment Aortic Valves for Patients With a Small Aortic Root: A Single-Center Experience. Ann Thorac Surg. 2020;110:1549-56. doi:10.1016/j.athoracsur.2020.02.030.Chang C, Raza S, Altarabsheh SE, et al. Minimally invasive approaches to surgical aortic valve replacement: a meta-analysis. Ann Thorac Surg. 2018;106:1881-9.Chang C, Raza S, Altarabsheh SE, et al. Minimally invasive approaches to surgical aortic valve replacement: a meta-analysis. Ann Thorac Surg. 2018;106:1881-9.Paparella D, Malvindi PG, Santarpino G, et al. Full sternotomy and minimal access approaches for surgical aortic valve replacement: a multicentre propensity-matched study. Eur J Cardio-Thoracic Surg Off J Eur Assoc Cardio-Thoracic Surg. 2020;57:709-16. doi:10.1093/ejcts/ezz286.Paparella D, Malvindi PG, Santarpino G, et al. Full sternotomy and minimal access approaches for surgical aortic valve replacement: a multicentre propensity-matched study. Eur J Cardio-Thoracic Surg Off J Eur Assoc Cardio-Thoracic Surg. 2020;57:709-16. doi:10.1093/ejcts/ezz286.Welp HA, Herlemann I, Martens S, Deschka H.Outcomes of aortic valve replacement via partial upper sternotomy versus conventional aortic valve replacement in obese patients. Interact Cardiovasc Thorac Surg. 2018;27:481-6. doi:10.1093/icvts/ivy083.Welp HA, Herlemann I, Martens S, Deschka H.Outcomes of aortic valve replacement via partial upper sternotomy versus conventional aortic valve replacement in obese patients. Interact Cardiovasc Thorac Surg. 2018;27:481-6. doi:10.1093/icvts/ivy083.Zubarevich A, Rad AA, Szczechowicz M, et al. Sutureless aortic valve replacement in high-risk patients with active infective endocarditis. J Thorac Dis. 2022;14:3178-86. doi:10.21037/jtd-22-486.Zubarevich A, Rad AA, Szczechowicz M, et al. Sutureless aortic valve replacement in high-risk patients with active infective endocarditis. J Thorac Dis. 2022;14:3178-86. doi:10.21037/jtd-22-486.Hassanin A, Afify H, Zook S, et al. Infective Endocarditis After Transcatheter Aortic Valve Implantation: A Systematic Review. Cardiol Rev. 2023;31:93-8. doi:10.1097/CRD.0000000000000460.Hassanin A, Afify H, Zook S, et al. Infective Endocarditis After Transcatheter Aortic Valve Implantation: A Systematic Review. Cardiol Rev. 2023;31:93-8. doi:10.1097/CRD.0000000000000460.Indelen C, Bas T, Kar A, et al. Cost-Effectiveness and Clinical Outcome of Transcatheter Versus Sutureless Aortic Valve Replacement. Heart Surg Forum. 2023;26:E284-91. doi:10.1532/hsf.5445.Indelen C, Bas T, Kar A, et al. Cost-Effectiveness and Clinical Outcome of Transcatheter Versus Sutureless Aortic Valve Replacement. Heart Surg Forum. 2023;26:E284-91. doi:10.1532/hsf.5445.Povero M, Miceli A, Pradelli L, et al. Cost-utility of surgical sutureless bioprostheses vs TAVI in aortic valve replacement for patients at intermediate and high surgical risk. Clinicoecon Outcomes Res. 2018;10:733-45. doi:10.2147/CEOR.S185743.Povero M, Miceli A, Pradelli L, et al. Cost-utility of surgical sutureless bioprostheses vs TAVI in aortic valve replacement for patients at intermediate and high surgical risk. Clinicoecon Outcomes Res. 2018;10:733-45. doi:10.2147/CEOR.S185743.Sohn SH, Jang M, Hwang HY, Kim KH. Rapid deployment or sutureless versus conventional bioprosthetic aortic valve replacement: A meta-analysis. J Thorac Cardiovasc Surg. 2018;155:2402-12.e5. doi:10.1016/j.jtcvs.2018.01.084.Sohn SH, Jang M, Hwang HY, Kim KH. Rapid deployment or sutureless versus conventional bioprosthetic aortic valve replacement: A meta-analysis. J Thorac Cardiovasc Surg. 2018;155:2402-12.e5. doi:10.1016/j.jtcvs.2018.01.084.Muneretto C, Solinas M, Folliguet T, et al. Sutureless versus transcatheter aortic valves in elderly patients with aortic stenosis at intermediate risk: A multi-institutional study. J Thorac Cardiovasc Surg. 2022;163:925-35.e5. doi:10.1016/j.jtcvs.2020.04.179.Muneretto C, Solinas M, Folliguet T, et al. Sutureless versus transcatheter aortic valves in elderly patients with aortic stenosis at intermediate risk: A multi-institutional study. J Thorac Cardiovasc Surg. 2022;163:925-35.e5. doi:10.1016/j.jtcvs.2020.04.179.Takagi H, Ando T, Umemoto T.Direct and adjusted indirect comparisons of perioperative mortality after sutureless or rapid-deployment aortic valve replacement versus transcatheter aortic valve implantation. Int J Cardiol. 2017;228:327-34. doi:10.1016/j.ijcard.2016.11.253.Takagi H, Ando T, Umemoto T.Direct and adjusted indirect comparisons of perioperative mortality after sutureless or rapid-deployment aortic valve replacement versus transcatheter aortic valve implantation. Int J Cardiol. 2017;228:327-34. doi:10.1016/j.ijcard.2016.11.253.

The authors declare that there are no conflicts of interest present.